Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Validation of a DKK1 in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors